European Commission to support better diagnosis of rare diseases
This article was originally published in Clinica
The European Commission adopted yesterday two documents to improve European action in the field of rare diseases. The aim of the Communication and proposal for a Council Recommendation on rare diseases is to set out an EU-wide strategy to support member states in diagnosing, treating and caring for the 36 million EU citizens with rare diseases.
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.